IND-Enabling Studies of Somatic Genome Editing Therapeutic Leads (U19)

Is this a Limited Submission?

Yes, this is a Limited Submission

There are special requirements to apply for this opportunity, since the sponsor limits how many applicants may apply per institution. You will need to submit an NOI and/or Pre-Proposal for review by a Campus Committee before applying.

See this page for more information

Limited Submission - Application Link(s):

Campus LOI Deadline

Application Deadline

Key Information

Direct Link to Opportunity

https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-015.html

Application Deadline

Fund Type

Grant

Funding Agency

National Institutes of Health

Agency Type

Federal

Internal or External

External

Status of Applicants

See Opportunity Website

Discipline(s)

See Opportunity Website

Contact

See Opportunity Website

Additional Details

Details:

*Please note that the listed U19 opportunity solicitations do not limit the number of applications from a given institution; however, NIH does require that all applications from a given institution are scientifically distinct. For this reason, the OVCRI is requiring Notices of Intent from all teams pursuing this U19. The OVCRI will monitor for duplications and will contact the affected teams in the event that duplications are detected. 

Date Posted: